30 December 2025 : Original article
Impact of COVID-19 on Kidney Transplant Outcomes: An 8-Year Study From the Czech Republic
Jan Roman ABDEF 1,2, František Jalůvka BDEF 1,2*, Petr Jelínek
DEF 1,2, Petr Ostruszka BF 1, Ján Hrubovčák DEF 1,2, Pavel Havránek ABD 1,3, Adéla Kondé CE 4,5, Zdeněk Lys BCE 3, Martin Drápela ABEF 3, Vaclav Prochazka AEF 2,6
DOI: 10.12659/AOT.950961
Ann Transplant 2025; 30:e950961
Table 4 Results of Kaplan-Meier analysis of the 4-year overall and failure-free survival of kidney recipients.
| Before COVID-19 (n=99) | COVID-19 pandemic (n=46) | |
|---|---|---|
| 1-year | 96.0 (92.2; 99.9) | 97.8 (93.7; 100.0) |
| 2-year | 91.9 (86.7; 97.5) | 97.8 (93.7; 100.0) |
| 3-year | 90.9 (85.4; 96.8) | 97.8 (93.7; 100.0) |
| 1-year | 95.9 (92.0; 99.9) | 95.6 (89.8; 100.0) |
| 2-year | 92.6 (87.5; 98.0) | 95.6 (89.8; 100.0) |
| 3-year | 90.4 (84.7; 96.6) | 95.6 (89.8; 100.0) |
| The values represent survival rates with 95% confidence intervals. Median survival time could not be determined. | ||